ARTICLE | Company News
IQWiG rebuffs Novo's NovoEight
April 15, 2014 11:30 PM UTC
Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said in a preliminary benefit assessment that NovoEight turoctocog alfa from Novo Nordisk A/S (CSE:NVO; NYSE:NVO) has "no additiona...